Author

Erik Abraham Williams

Beth Israel Deaconess Medical CenterORCID 0000-0002-9190-2450Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Rendon· 1 shared Adam P GiessiD· 1 shared Afshan SiddiqiD· 1 shared Alex Stuckey· 1 shared Alexander SieghartiD· 1 shared Alona SosinskyiD· 1 shared Ana Lisa Taylor TavaresiD· 1 shared Andreas David KistleriD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

A. Rendon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Acute promyelocytic leukemia with torque teno mini virus (TTMV)::RARA fusion: an approach to screening and diagnosis

Harrison Kwei Tsai, Mark F Sabbagh, Meagan Montesion, Erik Abraham Williams, Arnaldo Arbini, Daniel R. Boué, Emily M. Harris, Franziska Wachter, Leslie Grimmett, Andrew E. Place, Fabienne McClanahan Lucas, Valentina Nardi, Annette S. Kim, Carlo Brugnara, Barbara A. Degar, , Jacob R. Bledsoe

The paper describes a clinicopathologic approach and tools for diagnosing APL with TTMV::RARA fusion using NGS assays, identifying four cases with poor treatment outcomes.

medRxiv · Mar 29, 2024 · PreprintGenetic & Genomic Medicine

An intermediate effect size variant in UMOD confers risk for chronic kidney disease

Eric Gregory Olinger, Céline Schaeffer, Kendrah O. Kidd, Elhussein A. E. Elhassan, Yurong Cheng, Inès Dufour, Guglielmo Schiano, Holly R. Mabillard, Elena Pasqualetto, Patrick Hofmann, Daniel Guido Fuster, Andreas David Kistler, Ian Wilson, Stanislav Kmoch, Laure Raymond, , Magdalena Zarowiecki

The paper identifies an intermediate-effect variant in UMOD associated with chronic kidney disease risk and shows it has reduced disease severity compared to canonical ADTKD mutations.

Proceedings of the National Academy of Sciences · Aug 10, 2022Peer-reviewedGenetic & Genomic Medicine